Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Biological therapies use different ways to stimulate the immune system and stop
cancer cells from growing. Peripheral stem cell transplantation combined with biological
therapy may be an effective treatment for breast cancer.
PURPOSE: Phase I trial to study the effectiveness of interleukin-2 with filgrastim to
stimulate cell production in treating patients with stage IIIB, stage IV, metastatic, or
recurrent breast cancer who will undergo peripheral stem cell transplantation.